Insider · CIK 0001529193

Norton David Y

Reports to the SEC for 5 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001529193

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-27	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+21.1K sh	—	—	21,110
2025-06-12	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2024-05-09	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+39K sh	—	—	39,000
2023-06-02	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2022-06-16	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2022-03-29	CMPSCOMPASS Pathways plcS Sale	Director	SSale	−3,384 sh	$12.48	−$42.2K	20,356
2021-08-05	Keenova Therapeutics plcS Sale	Director	SSale	−5,080 sh	$0.26	−$1,334.008	0
2020-12-17	Keenova Therapeutics plcS Sale	Director	SSale	−5,080 sh	$0.40	−$2,054.352	0
2020-12-16	Keenova Therapeutics plcS Sale	Director	SSale	−21.8K sh	$0.43	−$9,462.057	5,080
2020-05-13	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−8,729 sh	$2.96	−$25.8K	26,167
2020-02-20	VIVUS INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-05-15	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−8,527 sh	$15.21	−$130K	15,500
2019-05-15	Keenova Therapeutics plcA Award	Director	AAward	+19.4K sh	—	—	34,896
2018-10-26	VIVUS INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-05-16	Keenova Therapeutics plcA Award	Director	AAward	+18.9K sh	—	—	24,027
2018-03-01	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−2,521 sh	$15.68	−$39.5K	5,080
2017-11-10	Keenova Therapeutics plcP Purchase	Director	PPurchase	+2,000 sh	$22.02	+$44K	7,601
2017-10-27	VIVUS INCM Exercise/Conversion	Director	MExercise/Conversion	+12.5K sh	—	—	70,245
2017-10-27	VIVUS INCD Disposition to Issuer	Director	DDisposition to Issuer	−3,125 sh	$0.70	−$2,187.5	67,120
2017-10-27	VIVUS INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000
2017-10-27	VIVUS INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−12.5K sh	—	—	0
2017-09-20	Keenova Therapeutics plcA Award	Director	AAward	+5,601 sh	—	—	5,601
2017-08-08	VIVUS INCM Exercise/Conversion	Director	MExercise/Conversion	+12.5K sh	—	—	60,870
2017-08-08	VIVUS INCD Disposition to Issuer	Director	DDisposition to Issuer	−3,125 sh	$1.01	−$3,156.25	57,745
2017-08-08	VIVUS INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−12.5K sh	—	—	12,500
2017-06-15	VIVUS INCD Disposition to Issuer	Director	DDisposition to Issuer	−3,125 sh	$1.17	−$3,656.25	48,370
2017-05-23	Syneos Health, Inc.A Award	Director	AAward	+2,693 sh	—	—	6,988
2017-05-08	VIVUS INCM Exercise/Conversion	Director	MExercise/Conversion	+12.5K sh	—	—	51,495
2017-05-08	VIVUS INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−12.5K sh	—	—	25,000
2017-02-08	VIVUS INCM Exercise/Conversion	Director	MExercise/Conversion	+12.5K sh	—	—	42,120
2017-02-08	VIVUS INCD Disposition to Issuer	Director	DDisposition to Issuer	−3,125 sh	$1.08	−$3,375	38,995
2017-02-08	VIVUS INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−12.5K sh	—	—	37,500
2017-01-13	VIVUS INCRestricted Stock UnitsA Award	Director	AAward	+50K sh	—	—	50,000
2016-10-31	VIVUS INCM Exercise/Conversion	Director	MExercise/Conversion	+3,125 sh	—	—	30,401
2016-10-31	VIVUS INCD Disposition to Issuer	Director	DDisposition to Issuer	−781 sh	$1.05	−$820.05	29,620
2016-10-31	VIVUS INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,125 sh	—	—	0
2016-09-30	VIVUS INCM Exercise/Conversion	Director	MExercise/Conversion	+3,125 sh	—	—	28,057
2016-09-30	VIVUS INCD Disposition to Issuer	Director	DDisposition to Issuer	−781 sh	$1.14	−$890.34	27,276
2016-09-30	VIVUS INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,125 sh	—	—	3,125
2016-08-31	VIVUS INCM Exercise/Conversion	Director	MExercise/Conversion	+3,125 sh	—	—	25,720
2016-08-31	VIVUS INCD Disposition to Issuer	Director	DDisposition to Issuer	−788 sh	$1.06	−$835.28	24,932
2016-08-31	VIVUS INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,125 sh	—	—	6,250
2016-07-31	VIVUS INCM Exercise/Conversion	Director	MExercise/Conversion	+3,125 sh	—	—	23,376
2016-07-31	VIVUS INCD Disposition to Issuer	Director	DDisposition to Issuer	−781 sh	$1.07	−$835.67	22,595
2016-07-31	VIVUS INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,125 sh	—	—	9,375
2016-06-30	VIVUS INCM Exercise/Conversion	Director	MExercise/Conversion	+3,125 sh	—	—	21,032
2016-06-30	VIVUS INCD Disposition to Issuer	Director	DDisposition to Issuer	−781 sh	$1.12	−$874.72	20,251
2016-06-30	VIVUS INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,125 sh	—	—	12,500
2016-05-30	VIVUS INCM Exercise/Conversion	Director	MExercise/Conversion	+21.9K sh	—	—	23,375
2016-05-30	VIVUS INCD Disposition to Issuer	Director	DDisposition to Issuer	−5,468 sh	$1.23	−$6,725.64	17,907

Recent filings

Accepted (ET)
May 294
Norton David Y0001529193-26-000002
SEC(opens sec.gov)
Jun 134
Norton David Y0001816590-25-000079
SEC(opens sec.gov)
May 134
Norton David Y0001816590-24-000094
SEC(opens sec.gov)
Jun 64
Norton David Y0001816590-23-000084
SEC(opens sec.gov)
Jun 174
Norton David Y0001816590-22-000057
SEC(opens sec.gov)
Mar 314
Norton David Y0001816590-22-000018
SEC(opens sec.gov)
Aug 94
Norton David Y0001235110-21-000021
SEC(opens sec.gov)
Dec 184
Norton David Y0000950138-20-000537
SEC(opens sec.gov)
Dec 184
Norton David Y0000950138-20-000531
SEC(opens sec.gov)
May 154
Norton David Y0000950138-20-000259
SEC(opens sec.gov)
Feb 244
Norton David Y0001123292-20-000325
SEC(opens sec.gov)
May 174
Norton David Y0000950138-19-000310
SEC(opens sec.gov)
Oct 294
Norton David Y0001123292-18-001041
SEC(opens sec.gov)
May 184
Norton David Y0000950138-18-000423
SEC(opens sec.gov)
Mar 54
Norton David Y0000950138-18-000214
SEC(opens sec.gov)
Nov 134
Norton David Y0000950138-17-000750
SEC(opens sec.gov)
Oct 314
Norton David Y0001123292-17-001646
SEC(opens sec.gov)

Companies

Address

COMPASS PATHWAYS PLC 33 BROADWICK STREET

LONDON, W1F 0DQ